212 related articles for article (PubMed ID: 23755832)
21. Vitamin Bc -Bearing Hydrophilic Photosensitizer Conjugate for Photodynamic Cancer Theranostics.
Kim J; Kim KS; Park SJ; Na K
Macromol Biosci; 2015 Aug; 15(8):1081-90. PubMed ID: 25829050
[TBL] [Abstract][Full Text] [Related]
22. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
[TBL] [Abstract][Full Text] [Related]
23. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy for rat pituitary tumor in vitro and in vivo using pheophorbide-a and white light.
Yano T; Uozumi T; Kawamoto K; Mukada K; Onda J; Ito A; Fujimoto N
Lasers Surg Med; 1991; 11(2):174-82. PubMed ID: 2034013
[TBL] [Abstract][Full Text] [Related]
25. MMP2-Targeting and Redox-Responsive PEGylated Chlorin e6 Nanoparticles for Cancer Near-Infrared Imaging and Photodynamic Therapy.
Hou W; Xia F; Alves CS; Qian X; Yang Y; Cui D
ACS Appl Mater Interfaces; 2016 Jan; 8(2):1447-57. PubMed ID: 26638778
[TBL] [Abstract][Full Text] [Related]
26. Active-targeted pH-responsive albumin-photosensitizer conjugate nanoparticles as theranostic agents.
Battogtokh G; Ko YT
J Mater Chem B; 2015 Dec; 3(48):9349-9359. PubMed ID: 32262934
[TBL] [Abstract][Full Text] [Related]
27. Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging.
Lee DE; Na JH; Lee S; Kang CM; Kim HN; Han SJ; Kim H; Choe YS; Jung KH; Lee KC; Choi K; Kwon IC; Jeong SY; Lee KH; Kim K
Mol Pharm; 2013 Jun; 10(6):2190-8. PubMed ID: 23586421
[TBL] [Abstract][Full Text] [Related]
28. Zinc-pheophorbide a-highly efficient low-cost photosensitizer against human adenocarcinoma in cellular and animal models.
Jakubowska M; Szczygieł M; Michalczyk-Wetula D; Susz A; Stochel G; Elas M; Fiedor L; Urbanska K
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):266-77. PubMed ID: 23993853
[TBL] [Abstract][Full Text] [Related]
29. Self-assembled glycol chitosan nanoparticles for disease-specific theranostics.
Yhee JY; Son S; Kim SH; Park K; Choi K; Kwon IC
J Control Release; 2014 Nov; 193():202-13. PubMed ID: 24845129
[TBL] [Abstract][Full Text] [Related]
30. Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications.
Na JH; Koo H; Lee S; Han SJ; Lee KE; Kim S; Lee H; Lee S; Choi K; Kwon IC; Kim K
Mol Pharm; 2016 Nov; 13(11):3700-3711. PubMed ID: 27654060
[TBL] [Abstract][Full Text] [Related]
31. Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
Yhee JY; Jeon S; Yoon HY; Shim MK; Ko H; Min J; Na JH; Chang H; Han H; Kim JH; Suh M; Lee H; Park JH; Kim K; Kwon IC
J Control Release; 2017 Dec; 267():223-231. PubMed ID: 28917532
[TBL] [Abstract][Full Text] [Related]
32. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
Benito-Miguel M; Blanco MD; Gómez C
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Near-Infrared Photodynamic Therapy Based on Targeted Upconversion Nanoparticles.
Zhou A; Wei Y; Chen Q; Xing D
J Biomed Nanotechnol; 2015 Nov; 11(11):2003-10. PubMed ID: 26554158
[TBL] [Abstract][Full Text] [Related]
35. In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.
Chang H; Yhee JY; Jeon S; Shim MK; Yoon HY; Lee S; Kim K
J Nanobiotechnology; 2023 Mar; 21(1):82. PubMed ID: 36894943
[TBL] [Abstract][Full Text] [Related]
36. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
[TBL] [Abstract][Full Text] [Related]
37. Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy.
Moret F; Menilli L; Battan M; Tedesco D; Columbaro M; Guerrini A; Avancini G; Ferroni C; Varchi G
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452091
[TBL] [Abstract][Full Text] [Related]
38. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy based on combined use of 5-aminolevulinic acid with a pheophorbide-a derivative for murine tumors.
Jin ZH; Miyoshi N; Ishiguro K; Takaoka K; Udagawa T; Tajiri H; Ueda K; Fukuda M; Kumakiri M
In Vivo; 2000; 14(4):529-33. PubMed ID: 10945169
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Targeting Glycol Chitosan Nanoparticles for Image-Guided Surgery of Rabbit Orthotopic VX2 Lung Cancer.
On KC; Rho J; Yoon HY; Chang H; Yhee JY; Yoon JS; Jeong SY; Kim HK; Kim K
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32635231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
